Insider buying last 90 days
No open-market insider purchases were filed for SNPS in the last 90 days.
From Form 4 filings, dated to when each was filed.
Every SNPS insider filing, plotted on the chart in Gekko.Open SNPS in Gekko
NASDAQ: SNPS
Synopsys (SNPS) Stock Analysis & Forecast
$384.97+3.80 (+1.0%)
Close on Sep 18, 2026. Page updated Sep 19, 9:15 pm ET.
Gekko Brief
AI summarySynopsys trades at $384.97, up 1% on the day, but remains below both its 50-day average of $402.16 and 200-day average of $446.48, with the shorter average also under the longer one. The GekkoIndex reading of 64 places the stock in the Accumulation zone. Shares sit close to Gekko Fair Value of $388.20, a gap of -0.8%. Over the past year the stock is down 9.5%, with a three-month return of -15.5% and a one-month return of -4.1%.
Recent activity centers on ownership and research news. Synopsys and IonQ demonstrated that quantum algorithms integrated into engineering simulation software can cut processing time for complex industrial models by up to 14.6%. Elsewhere, Bank of America Corp DE disclosed a new stake of 1,210,540 shares valued at approximately $539.99 million, while Corient Private Wealth LP reduced its position by 34.7%, selling 9,719 shares. CEO Sassine Ghazi sold 14,604 shares for approximately $5.47 million under a pre-arranged Rule 10b5-1 plan.
Looking ahead, the next earnings report is scheduled for 9 December 2026, 80 days out, placing it beyond a typical 20-trading-day window. Options activity over the last 30 days shows 2 unusual signals, with call premium of $4,143,639 against put premium of $199,070. Three billionaire holders and two trailblazer holders are noted. Seasonality over five years shows the next 20 trading days averaging -3%, positive in 2 of those years, a pattern worth noting alongside the current distance from moving averages.
Written by AI and checked automatically against the figures on this page. Generated Sep 20, 2026 from the data above.
Price vs fair value
Close $384.97200-day averageGekko Fair Value $388.20
Key stats
- Market cap
- $73.71B
- P/E ratio
- 66.2
- Forward P/E
- 21.5
- EPS, TTM
- $5.76
- Revenue, TTM
- $9.42B
- Profit margin
- 11.4%
- Dividend yield
- —
- Beta
- 1.23
- Volume
- 3.22M avg 2.03M
- 1-year return
- −9.5%
- Typical daily move
- ±3.7%
- Typical 20-day move
- ±7.2%
- 50-day average
- $402.16
- 200-day average
- $446.48
- Next earnings
- Dec 9 after close
- Shares outstanding
- 191.6M
Synopsys swing-trade checklist
Synopsys scores 3 supportive, 1 mixed and 2 headwinds across the 6 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
3 supportive1 mixed2 headwinds
- Trendheadwind
Below 50 and 200-day
Close $384.97 is below the 50-day ($402.16) and 200-day ($446.48) averages, and the 50-day is below the 200-day.
See the chart - GekkoIndexsupportive
64, Accumulation
Reading 64 is in the Accumulation zone.
See the GekkoIndex - Fair valuemixed
0.8% below
Price is within 5% of Gekko Fair Value (0.8% below).
See fair value - Smart moneysupportive
Leans bullish
Last 30 days: 2 unusual options signals.
See smart money - Earnings risksupportive
Reports in 80 days
Next report Dec 9, 2026, 80 days away — outside a typical 20-trading-day hold.
See earnings - Seasonalityheadwind
−3.0% on average
From this point in the calendar, the next 20 trading days averaged −3% over 5 years, rising in 2 of them.
See seasonality
A description of current data, not a recommendation. How this page works
Synopsys stock chart and price history
Synopsys closed at $384.97 on Sep 18, 2026, −9.5% over the past year, inside a 52-week range of $362.55 to $539.48.
Close50-day average200-day averageVolume
Use the left and right arrow keys to read daily values.
Performance Breakdown
- 1 month
- −4.1%
- 3 months
- −15.5%
- 6 months
- −10.1%
- 1 year
- −9.5%
The full SNPS chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open SNPS in Gekko
Follow Synopsys through every session
Put SNPS on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Track SNPS in GekkoFree for 7 days. No credit card required.
About Synopsys
Synopsys makes software used to design, test and build integrated circuits, giving engineers tools to lay out digital chips, verify their behavior through simulation and emulation, and prototype designs before manufacturing. It is known for its chip design and verification platforms, which cover everything from early architecture planning to debugging finished designs, and it also builds tools for programming FPGAs and for modeling optical and photonic systems.
Much of its business rests on licensing pre-built intellectual property blocks, covering common communication standards, analog components, processor cores, memory, and security functions, that chipmakers can drop into their own designs rather than build from scratch. Synopsys rounds this out with services such as security testing, training and managed support to help clients catch flaws during development, plus tools aimed at manufacturing. Its customers span electronics, automotive, medical, energy, financial services and other industrial fields worldwide.
Synopsys was founded in 1986 and is based in Mountain View, California. Its shares trade on the NASDAQ under the ticker SNPS.
- Listed
- NASDAQ
- Sector
- Technology services
- Industry
- Packaged software
- Website
- synopsys.com
Synopsys GekkoIndex: the smart money zone
Synopsys’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 64, in the Accumulation zone, up 1.3 points over five sessions.
64Accumulation
Up 1.3 points over five sessions.
Reading for Sep 18, 2026
What followed past readings in each zone
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 46 | +4.0% | +6.1% | ||
| Accumulation (current zone) | 252 | −0.2% | +1.7% | ||
| Neutral | 330 | −0.5% | −2.8% | ||
| Distribution | 33 | +0.1% | +2.3% | ||
| Selling | 1 | Too few readings yet | |||
Average SNPS share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Accumulation readings averaged +2.3% over 20 days. Past behaviour doesn’t guarantee future results.
Accumulation zone: Institutional interest building. About the five zones →
See every daily GekkoIndex reading plotted over the SNPS price, zone by zone.Track SNPS in Gekko
Is Synopsys stock overvalued? Gekko Fair Value
Synopsys trades 0.8% below Gekko Fair Value of $388.20, so the shares are about fair value on Gekko’s estimate.
Gekko’s own estimate of what Synopsys shares are worth, recalculated every trading day.
$388.20
Gekko Fair Value, Sep 19, 2026
0.8% below fair value · About fair value
Gekko Fair Value on every chart, with the gap to price updating daily.Open SNPS in Gekko
Synopsys insider and Congress trading
No open-market insider purchases were filed for Synopsys, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
Congress trades last 90 days
No trades in SNPS were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Congress disclosures for SNPS, plotted on the chart in Gekko.Open SNPS in Gekko
Buybacks
Synopsys has been buying back its own shares.
- Latest authorization
- $2.00B, Feb 25, 2026
- Bought back, quarter ended Jul 31, 2026
- $37.50M
- As a share of market cap
- 0.05%
From company filings.
Unusual options activity last 30 days
2signals, 95% of the flagged premium in calls.
Latest: Bullish flow on Sep 9, $2.49M in unusual premium.
Hedge funds and billionaires quarter ended Jun 30
5of the funds Gekko tracks hold SNPS.
0added1opened4trimmed1sold out
Every signal with its contract, strike and premium, and which funds are on each side.Unlock in Gekko
Synopsys earnings: next date and track record
Synopsys reports on Dec 9, 2026, after the close (80 days away), and beat the EPS estimate in 5 of its last 8 reports.
Next earnings report
Dec 9, 2026
Expected after the close, 80 days away
- EPS estimate
- $4.11
- Revenue estimate
- $2.56B
5 of 8reports beat the EPS estimate
±10.9%average move across the report
2 of 8reports followed by a gain
Share-price move across each report
Last earnings call, Aug 26, 2026 AI summary
- What they said
- Synopsys delivered Q3 FY2026 results exceeding guidance on revenue, non-GAAP operating margin, and EPS, driven by EDA outperformance, record hardware revenue, and strong Ansys integration. The company launched Multiphysics Fusion, its first joint Synopsys-Ansys product, validated by NVIDIA, Cisco, MediaTek, and Samsung Foundry with up to 10x faster design closure. Design IP returned to growth, and agentic AI initiatives showed strong traction with 30+ active customer engagements.
- Guidance
- Synopsys raised full-year revenue, non-GAAP operating margin, and EPS guidance. EDA growth is expected to accelerate to double digits in Q4 and for the full year. Multiphysics Fusion add-on capabilities are expected to contribute to EDA growth beginning in 2027.
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Aug 26, 2026 | $2.30 est $2.66 | $2.48B est $2.44B | +13.7% |
| May 27, 2026 | $0.00 est $3.16 | $2.28B est $2.25B | −10.1% |
| Feb 25, 2026 | $3.77 est $3.56 | $2.41B est $2.39B | −3.3% |
| Dec 10, 2025 | $2.90 est $2.78 | $2.25B est $2.25B | +2.4% |
| Sep 9, 2025 | $3.39 est $3.80 | $1.74B est $1.77B | −36.3% |
| May 28, 2025 | $3.67 est $3.39 | $1.60B est $1.60B | −11.1% |
| Feb 26, 2025 | $3.03 est $2.79 | $1.46B est $1.45B | −0.7% |
| Dec 4, 2024 | $3.40 est $3.30 | $1.64B est $1.63B | −9.6% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Synopsys stock forecast and analyst price targets
Analysts’ average 12-month price target for Synopsys is $545.93, +41.8% from the last close, from 15 firms rating the stock in the last 90 days.
$545.93consensus 12-month target, +41.8% from the last close
Now $384.97Avg $545.93
Low $450High $633
Each firm’s latest rating in the last 90 days: 15 firms.
Latest analyst actions
| Date | Firm | Target | vs price |
|---|---|---|---|
| Sep 8 | Morgan Stanley | $500 | +29.9% |
| Sep 1 | J.P. Morgan | $600 | +55.9% |
| Aug 27 | Needham | $580 | +50.7% |
| Aug 27 | Bank of America Securities | $500 | +29.9% |
| Aug 27 | Rosenblatt Securities | $575 | +49.4% |
+1.7%average 20-day move after past Accumulation readings
−3.0%average move over the next 20 trading days in the last 5 years
±3.7%typical daily move, from the 14-day average range
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Synopsys seasonality: the next 20 trading days
Over the next 20 trading days from Sep 19, Synopsys averaged −3.0% across the last 5 years, rising in 2 of them.
Next 20 trading days, by year
Average move and hit rate
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | −1.8% | 1 of 5 |
| Next 10 trading days | −3.4% | 1 of 5 |
| Next 15 trading days | −3.2% | 2 of 5 |
| Next 20 trading days | −3.0% | 2 of 5 |
| Next 30 trading days | −0.7% | 3 of 5 |
For scale, SNPS’s typical 20-trading-day move in either direction is about 7.2%.
Synopsys market cap and key statistics
Synopsys’s market cap is $73.71B, with a P/E ratio of 66.2 and revenue of $9.42B over the last twelve months.
Valuation
- Market cap
- $73.71B
- P/E ratio
- 66.2
- Forward P/E
- 21.5
- EPS, TTM
- $5.76
- Gekko Fair Value
- $388.20
Trading
- Volume
- 3.22M
- Avg volume, 20 days
- 2.03M
- 52-week high
- $539.48
- 52-week low
- $362.55
- Shares outstanding
- 191.6M
Financials
- Revenue, TTM
- $9.42B
- Profit margin
- 11.4%
- Return on equity
- 3.7%
- Quarterly earnings growth, YoY
- +89.3%
Risk and income
- Beta
- 1.23
- Typical daily move
- ±3.7%
- Typical 20-day move
- ±7.2%
Synopsys stock news this week
Coverage of Synopsys this week reads positive: 8 positive, 3 neutral and 1 negative headlines.
- IonQ, Synopsys Research Shows Quantum Boost Can Cut Simulation Time by Up to 14.6%BigGo Finance, Sep 18
- Corient Private Wealth LP Cuts Stock Position in Synopsys, Inc. $SNPSMarketBeat, Sep 18
- Should You Invest in Synopsys (SNPS) Based on Bullish Wall Street Views?Zacks Investment Research, Sep 17
- Investors Heavily Search Synopsys, Inc. (SNPS): Here is What You Need to KnowZacks Investment Research, Sep 17
- Synopsys (NASDAQ:SNPS) CEO Sassine Ghazi Sells 14,604 Shares of StockMarketBeat, Sep 16
- Bank of America Corp DE Makes New $539.99 Million Investment in Synopsys, Inc. $SNPSMarketBeat, Sep 16
Synopsys peers
Synopsys’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| MSFTMicrosoft | Neutral | 13.4% above |
| ORCLOracle | Neutral | 17.7% below |
| PLTRPalantir Technologies | Neutral | 11.3% above |
| PANWPalo Alto Networks | Neutral | 8.9% above |
| CRWDCrowdStrike | Neutral | 19.0% above |
| CRMSalesforce | Neutral | 1.3% below |
A peer links to its own page where one exists.
Synopsys stock FAQ
What is Synopsys’s market cap?
Synopsys’s market cap is $73.71B at the Sep 18, 2026 close of $384.97, with 191.6M shares outstanding. The shares trade on a P/E ratio of 66.2.
What is the Synopsys stock forecast?
The consensus analyst 12-month price target for Synopsys is $545.93, +41.8% from the last close. Of the 15 firms that rated the stock in the last 90 days, 14 rate it a buy, 1 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
Is Synopsys stock overvalued or undervalued?
On Gekko’s estimate Synopsys is about fair value: the Sep 18, 2026 close of $384.97 is 0.8% below Gekko Fair Value of $388.20. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
When does Synopsys report earnings next?
Synopsys is expected to report on Dec 9, 2026, after the market closes (80 days away). Analysts expect earnings of $4.11 per share on revenue of $2.56B. Synopsys beat the earnings estimate in 5 of its last 8 reports, moving 10.9% on average across the report.
What is Synopsys’s 52-week high and low?
Synopsys’s 52-week high is $539.48 and its 52-week low is $362.55; it closed at $384.97 on Sep 18, 2026, −9.5% over the past year.
Is Synopsys stock a buy right now?
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 3 of the 6 items with data read as supportive (gekkoindex, smart money and earnings risk), 1 as mixed (fair value) and 2 as headwinds (trend and seasonality). The checklist is a description of current data, not a recommendation.
Is there unusual options activity in Synopsys?
Gekko flagged 2 unusual options signals in Synopsys over the last 30 days, with $4.14M of flagged premium in calls and $199K in puts. The latest, bullish flow, was on Sep 9, 2026 with $2.49M in unusual premium. The signal-by-signal table is in Gekko.
How this page works
Prices and signals update after every US market close; the GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
See Synopsys the way Gekko members do
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,349 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.